Alba Therapeutics

About:

Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company.

Website: http://albatherapeutics.com

Top Investors: SV Health Investors, Alta Partners, HealthCap, Red Abbey Venture Partners, Maryland Venture Fund

Description:

Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba’s technology is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, asthma/COPD and acute lung injury.

Total Funding Amount:

$30M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Baltimore, Maryland, United States

Founded Date:

2004-01-01

Contact Email:

info(AT)albatherapeutics.com

Founders:

Blake M. Paterson

Number of Employees:

1-10

Last Funding Date:

2005-08-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai